183 related articles for article (PubMed ID: 38563495)
1. Receipt of RhD-positive whole blood for life-threatening bleeding in female children: A survey in alloimmunized mothers regarding minimum acceptable survival benefit relative to risk of maternal alloimmunization to anti-D.
Sherwood MR; Clayton S; Leeper CM; Yazer M; Moise KJ; Granger ME; Spinella PC
Transfusion; 2024 May; 64 Suppl 2():S100-S110. PubMed ID: 38563495
[TBL] [Abstract][Full Text] [Related]
2. Low titer group O whole blood and risk of RhD alloimmunization: Rationale for use in Finland.
Susila S; Ilmakunnas M; Lauronen J; Vuorinen P; Ångerman S; Sainio S
Transfusion; 2024 May; 64 Suppl 2():S119-S125. PubMed ID: 38240146
[TBL] [Abstract][Full Text] [Related]
3. Not as "D"eadly as once thought - the risk of D-alloimmunization and hemolytic disease of the fetus and newborn following RhD-positive transfusion in trauma.
Yazer MH; Panko G; Holcomb JB; Kaplan A; Leeper C; Seheult JN; Triulzi DJ; Spinella PC
Hematology; 2023 Dec; 28(1):2161215. PubMed ID: 36607150
[TBL] [Abstract][Full Text] [Related]
4. Rate of RhD-alloimmunization after the transfusion of RhD-positive red blood cell containing products among injured patients of childbearing age: single center experience and narrative literature review.
Yazer M; Triulzi D; Sperry J; Corcos A; Seheult J
Hematology; 2021 Dec; 26(1):321-327. PubMed ID: 33775237
[TBL] [Abstract][Full Text] [Related]
5. Neonatal and Obstetrical Outcomes of Pregnancies Complicated by Alloimmunization.
Bahr TM; Tweddell SM; Zalla JM; Dizon-Townson D; Ohls RK; Henry E; Ilstrup SJ; Kelley WE; Ling CY; Lindgren PC; O'Brien EA; Christensen RD
Pediatrics; 2024 Jun; 153(6):. PubMed ID: 38784990
[TBL] [Abstract][Full Text] [Related]
6. Maternal and child life years gained by transfusing low titer group O whole blood in trauma: A computer simulation.
Yazer MH; Leeper C; Spinella PC; Emery SP; Horvath S; Seheult JN
Transfusion; 2024 May; 64 Suppl 2():S93-S99. PubMed ID: 38404198
[TBL] [Abstract][Full Text] [Related]
7. Impact of red blood cell alloimmunization on fetal and neonatal outcomes: A single center cohort study.
Lieberman L; Callum J; Cohen R; Cserti-Gazdewich C; Ladhani NNN; Buckstein J; Pendergrast J; Lin Y
Transfusion; 2020 Nov; 60(11):2537-2546. PubMed ID: 32893897
[TBL] [Abstract][Full Text] [Related]
8. Rate of RhD-alloimmunization after the transfusion of multiple RhD-positive primary red blood cell-containing products.
Yazer MH; Triulzi DJ; Sperry JL; Seheult JN
Transfusion; 2021 Jul; 61 Suppl 1():S150-S158. PubMed ID: 34269438
[TBL] [Abstract][Full Text] [Related]
9. [The importance of antenatal immunoprophylaxis for prevention of hemolytic disease of the fetus and newborn].
Starcević M; Mataija M; Sović D; Dodig J; Matijević R; Kukuruzović M
Acta Med Croatica; 2011 Mar; 65(1):49-54. PubMed ID: 21568074
[TBL] [Abstract][Full Text] [Related]
10. The risk to future pregnancies of transfusing Rh(D)-negative females of childbearing potential with Rh(D)-positive red blood cells during trauma resuscitation is dependent on their age at transfusion.
Seheult JN; Stram MN; Pearce T; Bub CB; Emery SP; Kutner J; Watanabe-Okochi N; Sperry JL; Takanashi M; Triulzi DJ; Yazer MH
Vox Sang; 2021 Aug; 116(7):831-840. PubMed ID: 33491789
[TBL] [Abstract][Full Text] [Related]
11. Timing of RhD-positive red blood cell administration is associated with D-alloimmunization in injured patients.
Yazer MH; Spinella PC; Sperry J; Triulzi DJ; Leeper C
Transfusion; 2023 May; 63 Suppl 3():S54-S59. PubMed ID: 37067374
[TBL] [Abstract][Full Text] [Related]
12. Ethical considerations in the use of RhD-positive blood products in trauma.
Malone JR
Transfusion; 2024 May; 64 Suppl 2():S4-S10. PubMed ID: 38491917
[TBL] [Abstract][Full Text] [Related]
13. [Spontaneous antepartal RhD alloimmunization].
Studničková M; Holusková I; Durdová V; Kratochvílová T; Strašilová P; Marková I; Lubušký M
Ceska Gynekol; 2015 Dec; 80(6):401-4. PubMed ID: 26741153
[TBL] [Abstract][Full Text] [Related]
14. Survey of policies at US hospitals on the selection of RhD type of low-titer O whole blood for use in trauma resuscitation.
Clayton S; Leeper CM; Yazer MH; Spinella PC
Transfusion; 2024 May; 64 Suppl 2():S111-S118. PubMed ID: 38501231
[TBL] [Abstract][Full Text] [Related]
15. Fetal anemia due to non-Rhesus-D red-cell alloimmunization.
Moise KJ
Semin Fetal Neonatal Med; 2008 Aug; 13(4):207-14. PubMed ID: 18396474
[TBL] [Abstract][Full Text] [Related]
16. Rate of D-alloimmunization in trauma does not depend on the number of RhD-positive units transfused: The BEST collaborative study.
Seheult JN; Callum J; Delaney M; Drake R; Dunbar NM; Harm SK; Hess JR; Jackson BP; Javanbakht A; Moore SA; Murphy MF; Raval JS; Staves J; Tuott EE; Wendel S; Ziman A; Yazer MH;
Transfusion; 2022 Aug; 62 Suppl 1():S185-S192. PubMed ID: 35748692
[TBL] [Abstract][Full Text] [Related]
17. Immunological principle of development of red blood cell alloimmunization in pregnancy, hemolytic disease of the fetus and prevention of RhD alloimmunization in RhD negative women.
Roubalová L; Lubušký M
Ceska Gynekol; 2020; 85(6):408-416. PubMed ID: 33711901
[TBL] [Abstract][Full Text] [Related]
18. A curious case of anti-D antibody titer.
Hensley JG; Coughlin KP; Klein LL
J Midwifery Womens Health; 2009; 54(6):497-502. PubMed ID: 19879523
[TBL] [Abstract][Full Text] [Related]
19. Anti-D in a mother, hemizygous for the variant RHD*DNB gene, associated with hemolytic disease of the fetus and newborn.
Quantock KM; Lopez GH; Hyland CA; Liew YW; Flower RL; Niemann FJ; Joyce A
Transfusion; 2017 Aug; 57(8):1938-1943. PubMed ID: 28639307
[TBL] [Abstract][Full Text] [Related]
20. Intramuscular versus intravenous anti-D for preventing Rhesus alloimmunization during pregnancy.
Okwundu CI; Afolabi BB
Cochrane Database Syst Rev; 2013 Jan; (1):CD007885. PubMed ID: 23440818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
